107 related articles for article (PubMed ID: 1385274)
1. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
Silvestri F; Banavali S; Baccarani M; Preisler HD
Haematologica; 1992; 77(3):265-73. PubMed ID: 1385274
[TBL] [Abstract][Full Text] [Related]
2. Positive stem cell selection--basic science.
Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
[TBL] [Abstract][Full Text] [Related]
3. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
4. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.
Inaba T; Shimazaki C; Hirata T; Ashihara E; Okawa K; Oku N; Goto H; Fujita N; Tsuji H; Nakagawa M
Bone Marrow Transplant; 1994 May; 13(5):527-32. PubMed ID: 7519935
[TBL] [Abstract][Full Text] [Related]
6. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
9. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
10. CD34-positive cell selection by immunomagnetic beads and chymopapain.
Silvestri F; Banavali S; Yin M; Gopal V; Savignano C; Baccarani M; Preisler HD
Haematologica; 1992; 77(4):307-10. PubMed ID: 1385276
[TBL] [Abstract][Full Text] [Related]
11. CD34+ selected cells in clinical transplantation.
Collins RH
Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
Kinniburgh D; Russell NH
Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
[TBL] [Abstract][Full Text] [Related]
13. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
Smiler D; Soltan M; Albitar M
Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
[TBL] [Abstract][Full Text] [Related]
14. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
15. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.
Huss R; Lange C; Weissinger EM; Kolb HJ; Thalmeier K
Stem Cells; 2000; 18(4):252-60. PubMed ID: 10924091
[TBL] [Abstract][Full Text] [Related]
16. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
17. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
18. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S
Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849
[TBL] [Abstract][Full Text] [Related]
19. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
20. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
